DiviDrip · ZLAB

ZLAB — Zai Lab Limited

ZLAB is Zai Lab Limited (Healthcare) — a non-dividend-paying stock. Trading at $26.48. Market cap: $2.97B. Capital Quality Rank: 24/100 — Capital destroyer.

Stock snapshot

Price$26.48
Market cap$2.97B
SectorHealthcare
ExchangeNGM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)24 / 100 · Capital destroyer
ROIC (TTM)-504.5%
Revenue CAGR (3y)28.9%
Shareholder buyback yield-30.00%
Altman Z-score zoneDistress

About ZLAB

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Listed2017Employees1.8KHQShanghaiSectorHealthcareWebsitezailaboratory.com

Related non-dividend companies

Other non-dividend stocks investors research alongside ZLAB. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is ZLAB's current stock price?

ZLAB (Zai Lab Limited) is currently trading at $26.48.

Does ZLAB pay a dividend?

ZLAB (Zai Lab Limited) does not currently pay a regular dividend.

What is ZLAB's Capital Quality Rank?

ZLAB has a Capital Quality Rank of 24/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track ZLAB in DiviDrip

Add ZLAB to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow